Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTHAR in MS Relapses
NCT03021317Phase 4Terminated
- Sponsor
- University of Chicago
- Start
- Dec 2016
- Primary completion
- Oct 2020
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 4, open-label, single-arm trial of repository corticotropin injection in multiple sclerosis (MS), sponsored by University of Chicago. Primary endpoint: Change in T1 Lesion Relaxation Time. Started Dec 2016; status: terminated.
02
Drugs
repository corticotropin injection
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT03021317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03021317.